Skip to main content
Figure 3 | BMC Immunology

Figure 3

From: Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype - implications for the role of transglutaminase in coeliac disease

Figure 3

Scanning electron microscopy (SEM) images of DCs following treatment with ECM proteins. Dendritic cells, following 48 h treatment with TG[high], TG [mid] or TG [low] were mounted onto aluminium stubs, gold coated under an argon atmosphere before being imaged using a JOEL 6060LV variable pressure SEM operating at 10 kV accelerating voltage at x750 and x1500 magnifications (n = 1). Sample treatments correspond to untreated (CTRL) and TG-2 activity defined as 0.039 U/mL (TG-2 [high]), 0.0036 U/mL (TG-2 [mid]) or 0.00022 U/mL (TG-2 [low]).

Back to article page